Istituto Europeo di Oncologia

Name

Istituto Europeo di Oncologia

Legal name

Istituto Europeo di Oncologia Srl

Website

https://ieo.it

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

5,001–10,000 employees

Ownership category

akta.pro rank

Product category

Oncology Hospital Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), General Medical and Surgical Hospitals (6221)

SIC

Services-Hospitals (8060), Services-General Medical & Surgical Hospitals, Nec (8062)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industries

Surgical Oncology (HLAKAFAG), Medical Oncology (HLAKAFAB), Genitourinary Oncology (HLAKAFAM), Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM)

Keywords

• Oncology hospital services
• Cancer treatment center
• Surgical oncology care
• Clinical cancer research
• Cancer prevention programs

Headquarters

HQ city

Milan

HQ country

Italy

HQ region

Europe

Offices5 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. National Health Service (SSN) / Servizio Sanitario Nazionale: IEO provides services covered by the Italian National Health Service, subject to regional budget caps. The institution annually exceeds its SSN spending ceiling, delivering services even when not reimbursed by the Region.
2. Private/Out-of-Pocket (Solvenza): Private-pay patients can access all services on a fee-for-service basis outside the SSN framework.
3. Insurance/Convenzioni: Services delivered under insurance and affiliated convention agreements for patients with private health coverage.
4. Clinical Research and Grants: IEO conducts clinical trials often in collaboration with international research institutions. Al 31 December 2025, there were 692 active studies with 6,191 participants enrolled in 2025. The institution holds AIRC grants for high-innovation studies in breast cancer treatment.
5. Smartfood Programme - Corporate Wellness and Certification: Smartfood provides nutrition consulting to companies within welfare programs, optimizing food choices in canteens and vending machines, organizing seminars for employees. The program also developed the Smartfood Certification Mark for food companies meeting nutritional standards.

Pricing tiers

Go-to-market motion2 records

Distribution channels6 records

Marketing channels8 records

Core offering

Istituto Europeo di Oncologia (IEO) is a specialized cancer hospital and research institute in Milan providing comprehensive oncology services across the full patient pathway: cancer prevention, genetic risk assessment, diagnosis, multimodal treatment (surgery, medical oncology, radiotherapy, proton therapy, nuclear medicine), rehabilitation, and follow-up. It integrates laboratory and clinical research with real-time patient care and conducts 692 active clinical trials.

Product overview

Istituto Europeo di Oncologia (IEO) operates as a comprehensive oncology center offering integrated healthcare services, research, and prevention programs. The institute's portfolio includes clinical services such as the e-CUP electronic booking system, Televisite telemedicine consultations, IEO Second Opinion remote consultations, and the IEO Check Up prevention program. The Smartfood sub-brand provides nutrition and communication science programs focused on cancer prevention through healthy eating education. The Division of Prevention and Genetic Oncology offers oncogenetics counseling and genetic testing services. The recently launched BIANCA Digital Biobank represents IEO's entry into AI-powered digital pathology, using computer vision algorithms to analyze digitized tissue samples.

Differentiator

Problem solved

Functional benefit

Brands

• SmartFood: Nutrition and communication science program focused on cancer prevention through diet and healthy lifestyle recommendations
• IEO Check Up
• IEO Education
• IEO International Office

Products and services

• Surgical Oncology Services Surgical treatment of solid tumors across all major cancer types delivered through multidisciplinary teams at the Milan campus; for individual oncology patients.
• Medical Oncology, Radiotherapy and Proton Therapy Systemic anticancer therapies, radiotherapy, nuclear medicine and proton therapy for individual cancer patients.
• IEO Check Up Comprehensive preventive health screening and cancer detection program for asymptomatic individuals seeking early diagnosis and lifestyle risk assessment.
• Televisite Remote specialist consultations delivered via video call for follow-up visits and clinical advice to oncology patients unable to travel to Milan.
• IEO Second Opinion Remote expert second-opinion consultations on cancer diagnosis and treatment plans for patients and referring physicians.
• Division of Prevention and Genetic Oncology Oncogenetics counseling, genetic testing, personalized risk assessment and prevention programs for individuals with family history of cancer or identified high-risk mutations.
• Medici IEO nella Tua Città Network of affiliated partner clinics across Italy where IEO specialists provide in-person consultations, enabling regional patients to access IEO expertise locally.
• Smartfood Program Nutrition science program offering corporate wellness consulting, employee seminars, canteen optimization, and food-product certification under the Smartfood Mark; targeted at companies and the general public.
• BIANCA Digital Biobank AI-based digital biobank that digitizes histopathological samples using ultra-high-resolution scanners and self-annotation AI algorithms to support pathologists in identifying biomarkers and producing diagnostic analyses.
• IEO International Office Dedicated office coordinating consultations, treatment planning and care logistics for international (non-Italian) patients seeking access to IEO oncology services.

Quantifiable outcome

• Over 1 million patients treated since 1994, with ~50,000 new patients annually
• +5 more outcomes

Named customers6 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature6 records

Partnerships

17 partnerships are on record, tiered core and minor.

• Laife ReplycoreTechnology or Integration · 1 December 2024IEO's Pathology Division partnered with Laife Reply (a Reply Group company specializing in AI and digital transformation) on the BIANCA project - the first AI-based digital biobank in Italy. The project, selected under Italy's 'Agreements for Innovation' programme, launched at the end of 2024 with a planned 30-month duration. The partnership aims to digitize archived tissue samples using ultra-high-resolution scanners and train AI algorithms to support pathologists in histological and molecular analysis, identifying biomarkers and reducing diagnostic costs and time. Laife Reply collaborates with IEO's pathology and information systems teams to develop scalable AI frameworks for hospitals and healthcare organizations.
• University of Milan (Università degli Studi di Milano)coreStrategic or Co-development PartnerAcademic partnership for medical training, research collaboration, and university programs. IEO collaborates with the University of Milan on undergraduate programs including Radiology Techniques, Nursing, and university master's programs in Molecular Pathology, Nutrition and Dietetics.
• SEMM (European School of Molecular Medicine)coreStrategic or Co-development PartnerIEO hosts and collaborates with SEMM, the European School of Molecular Medicine, which operates as a graduate school and research institute focused on molecular medicine, contributing to IEO's educational mission.
• AIRC (Associazione Italiana per la Ricerca sul Cancro)coreStrategic or Co-development PartnerIEO Breast Surgery holds AIRC grants for high-innovation studies in multidisciplinary breast cancer treatment. AIRC is Italy's leading cancer research association providing grant funding for IEO's clinical research programs.
• Fondazione IEO-MONZINOcoreStrategic or Co-development PartnerFoundation affiliated with IEO dedicated to supporting cardiac oncology (cardioncology) and cardiovascular health research in cancer patients. Fondazione IEO-MONZINO raises funds for research and supports integrated cardiac-oncology care at IEO.
• Centro Cardiologico MonzinocoreStrategic or Co-development PartnerCardiology center that is part of the IEO group, dedicated to cardiovascular care and research. It operates in conjunction with Fondazione IEO-MONZINO to provide integrated cardiac-oncology services.
• GISCAD (Gruppo Italiano per lo Studio dei Carcinomi e delle Malattie Dismorfogenetiche)minorStrategic or Co-development PartnerIEO participates in the ItaLynch clinical study sponsored by GISCAD, focused on mainstreaming the diagnosis of Lynch Syndrome. GISCAD is an Italian research consortium for cancer and dysmorphogenetic diseases.
• Harvard Medical School (Boston)coreStrategic or Co-development PartnerIEO's Smartfood programme adapted the 'Healthy Eating Plate' concept from Harvard Medical School's Harvard T.H. Chan School of Public Health to create the 'Piatto Smart' (Smart Plate), a visual guide for balanced meals based on the Mediterranean diet model.
• International Breast Cancer Study Group (IBCSG)coreStrategic or Co-development PartnerDr. Viviana Galimberti serves on the Scientific Committee of IBCSG. IEO participates in international breast cancer clinical trials coordinated by IBCSG, contributing to global breast cancer research.
• World Cancer Research Fund (WCRF)coreStrategic or Co-development PartnerIEO's Smartfood programme shares and disseminates the WCRF's 10 recommendations for cancer prevention. Smartfood translates and explains WCRF evidence-based nutrition guidelines for the Italian public.
• Regione Lombardia (Lombardy Regional Government)coreStrategic or Co-development PartnerRegional government partnership for National Health Service (SSN) service delivery and accreditation. IEO works with Regione Lombardia on wait list management (PRGLA), mammography screening programs, and healthcare planning. IEO is a major provider of SSN-covered oncology services in Lombardy.
• Food Industry Partners (Smartfood Certification)minorStrategic or Co-development PartnerSmartfood collaborates with food industry companies for product research and development, resulting in the Smartfood Certification Mark for products meeting nutritional standards. Collaborations have produced certified food products available to consumers.
• Senologica srl (La Spezia)minorChannel Partner/ Reseller/ DistributorPartner clinic in La Spezia where IEO doctors (Bernardo Bonanni, Viviana Galimberti, Gianmatteo Pagani, Francesca De Lorenzi) travel to provide specialized consultations. Enables patients in the Liguria region to access IEO breast cancer and prevention expertise locally.
• Studio Michelangelo (Florence)minorChannel Partner/ Reseller/ DistributorPartner clinic in Florence where Dr. Francesca De Lorenzi provides reconstructive surgery consultations for Tuscany region patients.
• Affidea Nuova Lamp (Turin)minorChannel Partner/ Reseller/ DistributorPartner diagnostic center in Turin where Dr. Gianmatteo Pagani performs senology consultations for Piedmont region patients.
• OECI (Organisation of European Cancer Institutes)minorStrategic or Co-development PartnerIEO is accredited by OECI (Organisation of European Cancer Institutes), a European consortium of cancer research and treatment institutions, demonstrating compliance with European cancer care standards.
• CertiqualityminorStrategic or Co-development PartnerIEO holds quality certifications recognized by Certiquality, an Italian certification body for quality management systems in healthcare organizations.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Gustave Roussy: Gustave Roussy is the largest comprehensive cancer center in Europe, based in Villejuif, France. It is the most direct functional peer to IEO: a dedicated oncology hospital combining clinical care, translational research, and clinical trials at national-leading scale, competing for international patients and pharma-sponsored trials across Europe.
• The Royal Marsden NHS Foundation Trust: The Royal Marsden is the UK's leading dedicated cancer hospital, operating alongside the Institute of Cancer Research. It mirrors IEO's model of combining specialty oncology inpatient and outpatient care with a high-volume clinical research portfolio, and similarly attracts international patients and competes for global trial sponsorships.
• Karolinska University Hospital: Karolinska University Hospital in Stockholm is one of Europe's largest academic medical centers with a deeply integrated oncology program and Karolinska Institutet research linkage. It is comparable to IEO in combining a publicly-funded, high-volume specialty cancer service with a major translational research engine and Nordic/European trial leadership.
• Memorial Sloan Kettering Cancer Center: MSK is the global benchmark for dedicated cancer specialty hospitals with integrated research. Like IEO, it pioneered surgical and diagnostic oncology techniques, runs a large clinical trial portfolio, and serves a significant international patient population. It sets the standard against which IEO's outcomes and reputation are benchmarked in Newsweek rankings.
• MD Anderson Cancer Center: MD Anderson is the world's largest dedicated cancer center, operating under the University of Texas system. It shares IEO's structure of high-volume specialty oncology care paired with a major clinical research mission and serves as the reference competitor for international patient acquisition and oncology trial leadership globally.
• Humanitas Research Hospital: Humanitas is a leading Italian private teaching and research hospital near Milan with a strong oncology program and IRCCS-equivalent research credentials. It is IEO's most direct domestic competitor, competing for the same Lombardy/SSN patient pool, private-pay oncology cases, and clinical trial sponsors in northern Italy.
• Vall d'Hebron Institute of Oncology (VHIO): VHIO is a leading Spanish translational oncology research center embedded within the Vall d'Hebron University Hospital in Barcelona. It is comparable to IEO in combining high-volume clinical oncology with a strong translational/preclinical pipeline and clinical trial portfolio, and is a peer within southern European oncology networks.

Broad incumbents

• Charité – Universitätsmedizin Berlin: Charité is one of Europe's largest university hospitals with comprehensive oncology services embedded within a broader multi-specialty portfolio. It overlaps with IEO's oncology capabilities but is not a dedicated cancer specialty hospital, positioning it as a broader incumbent rather than a direct competitor for IEO's specialty niche.

Emerging players

• Istituto Europeo di Oncologia — no; IFOM (FIRC Institute of Molecular Oncology): IFOM is a Milan-based molecular oncology research institute with strong translational focus and limited direct patient care. It is comparable to IEO's research mission and shares the Milan life-sciences ecosystem, but operates as a research-first entity rather than a specialty cancer hospital.

Regional players

• Centro di Riferimento Oncologico (CRO) Aviano: CRO Aviano is a publicly-funded Italian IRCCS oncology center in Friuli-Venezia Giulia. It is comparable to IEO as a national IRCCS-designated cancer center but serves a different regional catchment, making it a domestic peer rather than a direct competitor for the Lombardy patient base.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/IEOufficiale
• YouTubeyoutube.com/channel/UC7FVHO7OKgIKfB-NqX8Qv_g
• Facebookfacebook.com/Internationalpatientoffice
• Instagraminstagram.com/smartfoodieo
• LinkedInlinkedin.com/company/ieo-istituto-europeo-di-oncologia

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Istituto Europeo di Oncologia